Navigation Links
New Therapies may Help to Avoid Transplant in Some Heart Failure Patients

Implanted pumps improve heart function for some end-stage heart patients thereby allowing them to forgo heart transplantation, according to a study in the Journal of the American Heart Association.

The heart-assist devices also significantly improved the cardiac function in many other heart failure patients.

"This suggests that, while the devices alone may not be sufficient to allow a meaningful number of patients to come off the heart pump instead of having a heart transplant, there may be other therapies that can be added to enhance recovery," said Simon Maybaum, M.D., lead author of the study.

In end-stage heart failure, the heart weakens, gets larger and shows other signs of deterioration. Implantable heart pumps, called left ventricular assist devices (LVADs), pump blood through the body, which lets the hearts main pumping chamber rest. Pumps are currently approved for two purposes:

To help keep patients with end-stage heart failure alive until a donor heart becomes available for transplantation.
To serve as a long-term therapy for patients deemed unacceptable for a heart transplant.

However, for some time, transplant specialists have debated the potential for LVADs to be used as a "bridge to recovery" for the patients own heart. Prior small studies have yielded contrasting results. "Some centers were reporting that up to a third of their patients implanted with a heart pump were able to come off the pump without a transplant, and some centers were saying they just did not have that experience," said Maybaum, associate professor of clinical medicine and medical director of the Center for Advanced Cardiac Therapy at the Albert Einstein College of Medicines Montefiore Medical Center in New York City.

To resolve these inconsistent findings, researchers from seven major U.S. heart transplant centers formed the LVAD Working Group. They enrolled 67 patients with end-s
'"/>




Page: 1 2 3

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Preventive Therapies Found to be More Effective in Managing Migraines
3. Ayurvedic Therapies Cashing In On Medical Tourism
4. Immune-Boosting Therapies Of No Use In Preventing Miscarriage
5. Non Hormonal Therapies for Menopause Not Proved to be Effective
6. Need for More Talking Therapies for Treating Depression
7. Are Alternative Therapies A Reliable Alternative?
8. Special Behavioral Therapies made Women more likely to Attempt Suicide
9. Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children
10. Alternative Therapies May Not Ease Menopause Symptoms
11. Emerging Therapies for Skin Cancer Treatment
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...apy, or water exercise, may improve strength and m...chers from Australia studied more than 100 patient...Patients were divided into three groups. The first... swimming pool, the second exercised in a gym, and...
... has switched from mortality and longevity to heal...o longer is it only important that one lives longe...lso be considered.” A new study shows more benefi...later years. The research finds women who have an ...
...ward in their search for a cure for diabetes. A ne...ppear to develop into insulin producing //pancreat...tion for patients with diabetes. The latest resea... a treatment that cures advanced type 1 diabetes i...
...g newborns for biochemical genetic disorders may i...rents. However, researchers say false-positive scr...ts. Previously, screening for genetic disorders r...s can screen for up to 20 genetic disorders with j...
Other Medicine News:Health News:Screening Newborns Questioned 2
(Date:9/4/2008)...he treatment of Acute Myeloid ...Newswire/ -- Celator Pharmaceuticals today,announc...has granted orphan,drug designation to CPX-351 (Cy...treatment of Acute Myeloid Leukemia (AML)., Celat...d Phase 2,studies with CPX-351. The first Phase 2 ...
(Date:9/4/2008)...-- Southern Research Institute,today announced tha...cted,the organization to participate in the newly-... Network (MLPCN). The MLPCN -- a collaborative,res...s Program which is,designed to benefit human healt...e and validate future targets for drug discovery.,...
(Date:9/4/2008)...on for Targeted Therapies That Ensure...BEACH, Calif., and AMSTERDAM, Netherlands, Sept. 4...lar cancer diagnostics,today announced the launch...ows physicians to quantitatively determine the gen... progesterone receptor (PR) and Human Epidermal,gr...
(Date:9/3/2008)...arch and Education Foundation,s Within Our Reach ... Treating and Understanding RA...time during its,unprecedented initiative to find a...ge of Rheumatology Research and Education Foundati...arch funded by the Within Our,Reach: Finding a Cur...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Melvin receives Salivary Research Award 22799 1Atchison receives Behavioral Epidemiological and Health Services Research Award 22796 1Atchison receives Behavioral Epidemiological and Health Services Research Award 22796 2Statewide Wellness Awards Competition Now Open for Nominations 22794 1Statewide Wellness Awards Competition Now Open for Nominations 22794 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 1BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 3BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 4
...E)--May 7, 2007 - NanoViricides,Inc. (Pink Sheets...,against rabies and BSL3 in vitro studies against ... Annual Symposium of the Pan,American Society for ...2. (Pan American Society for Clinical Virology (PA...es against Clade 2 H5N1, a Dec. 2006 isolate in,Vi...
...-1001 into Later Stage Clinical,Trials, BALTIMORE,...rporation today announced preliminary results from...cts with Celiac Disease (CD), an,autoimmune diseas...ates. Alba,s study, the first Phase IIa trial in C...AT-1001 in CD, was designed to,evaluate the safety...
Other Medicine Technology:NanoViricides Drugs Found To Be Highly Effective Against Most,Recent Strain of the H5N1 Avian Flu Virus 2Alba Therapeutics Corporation Reports Preliminary Phase IIa,Clinical Trial Results for AT-1001 for the Treatment of Celiac,Disease 2Alba Therapeutics Corporation Reports Preliminary Phase IIa,Clinical Trial Results for AT-1001 for the Treatment of Celiac,Disease 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: